Antimicrobial Agents and Chemotherapy, volume 65, issue 5

Nybomycin inhibits both fluoroquinolone-sensitive and fluoroquinolone-resistant escherichia coli DNA gyrase

Alina A. Sofronova 2
Ekaterina A Berdnikovich 2
Tinashe P Maviza 3
Yan A Ivanenkov 7, 8
Petr V. Sergiev 1, 3, 4, 9
Ilya A Osterman 1, 3
Olga A. Dontsova 1, 3, 9, 10
Show full list: 13 authors
Publication typeJournal Article
Publication date2021-04-19
scimago Q1
wos Q1
SJR1.357
CiteScore10.0
Impact factor4.1
ISSN00664804, 10986596
PubMed ID:  33593838
Pharmacology
Infectious Diseases
Pharmacology (medical)
Abstract

Bacterial type II topoisomerases, DNA gyrase and topoisomerase IV, are targets of many antibiotics, including fluoroquinolones (FQs). Unfortunately, a number of bacterial species easily acquire resistance to FQs by mutations in either DNA gyrase or topoisomerase IV genes.

Top-30

Journals

1
1

Publishers

1
2
1
2
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Share
Cite this
GOST | RIS | BibTex
Found error?